Company Profiles

driven by the PitchBook Platform

CMDBioscience

Description

Developer of peptide drug designed to drive innovative peptide drug discovery and build value through strategic partnering arrangements with leading companies and academic institutions. The company's peptide drugs are made, using computational methods that enables users to have multi-function peptide drugs for leukemia and lymphoma.

2006

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$250k

Latest Deal Amount

$6.98M

Total Amount Raised

Description

Developer of peptide drug designed to drive innovative peptide drug discovery and build value through strategic partnering arrangements with leading companies and academic institutions. The company's peptide drugs are made, using computational methods that enables users to have multi-function peptide drugs for leukemia and lymphoma.

Website:

www.cmdbioscience.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Social/Platform Software
Drug Discovery

Primary Office

554 Boston Post Road Suite 318 Orange, CT 06477United States +1 (203) 298-4251
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore CMDBioscience's full profile, request a free trial.

CMDBioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

CMDBioscience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

CMDBioscience Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
Enhanced Capital PartnersAsset ManagerMinority000 0000000 0000
LaunchCapitalVenture CapitalMinority000 0000000 0000
Mohegan TribeOtherMinority000 0000000 0000
Connecticut Innovations Venture Capital
Enhanced Capital Partners Asset Manager
LaunchCapital Venture Capital
Mohegan Tribe Other

CMDBioscience Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Joseph Audie Ph.DChief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member
Charles Boyd Ph.DChief Investigational Scientist
David Diller Ph.DSenior Director of Computational Chemistry
Mark Jarosinski Ph.DSenior Director, Peptide Medicinal Chemistry & Business Development
Joseph Audie Ph.D Chief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member
Charles Boyd Ph.D Chief Investigational Scientist
David Diller Ph.D Senior Director of Computational Chemistry
Mark Jarosinski Ph.D Senior Director, Peptide Medicinal Chemistry & Business Development

CMDBioscience Board Members (4)

NameRepresentingRoleSinceContact
Info
Daniel WagnerConnecticut InnovationsManaging Director, Investments000 0000
Gerald VovisCMDBioscienceBoard Member000 0000
Joseph Audie Ph.DCMDBioscienceChief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member000 0000
Konstantine DrakonakisLaunchCapitalVenture Partner000 0000
Daniel Wagner Managing Director, Investments Connecticut Innovations
Gerald Vovis Board Member CMDBioscience
Joseph Audie Ph.D Chief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member CMDBioscience
Konstantine Drakonakis Venture Partner LaunchCapital
Request full access to PitchBook